Cental Macular Thickness in Patients with Type 2 Diabetes Mellitus without Clinical Retinopathy

Table 3

Relationship between central macular thickness (CMT), glycosylated hemoglobin (HbA1c), and fasting blood glucose levels in patients with type 2 diabetes without clinical retinopathy.

Parameters	Study group		Control group
	𝑟	𝑃	𝑟	𝑃
CMT-HbA1c	−0.077	NS	0.001	NS
CMT-fasting glucose	−0.091	NS	0.011	NS

CMT: central macular thickness, HbA1c: glycosylated hemoglobin, 𝑃: statistic value, and 𝑟: relation between two variables. NS: nonsignificant, study group: patients with type 2 diabetes without clinical retinopathy, and control group: healthy subjects.